Voziyan PA - Search Results

1

Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: mechanism of action of pyridoxamine.

Chetyrkin SV, Zhang W, Hudson BG, Serianni AS, Voziyan PA. Chetyrkin SV, et al. Among authors: voziyan pa. Biochemistry. 2008 Jan 22;47(3):997-1006. doi: 10.1021/bi701190s. Epub 2007 Dec 28. Biochemistry. 2008. PMID: 18161948

2

A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation.

Voziyan PA, Metz TO, Baynes JW, Hudson BG. Voziyan PA, et al. J Biol Chem. 2002 Feb 1;277(5):3397-403. doi: 10.1074/jbc.M109935200. Epub 2001 Nov 29. J Biol Chem. 2002. PMID: 11729198 Free article.

3

Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.

Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG. Voziyan PA, et al. J Biol Chem. 2003 Nov 21;278(47):46616-24. doi: 10.1074/jbc.M307155200. Epub 2003 Sep 15. J Biol Chem. 2003. PMID: 12975371 Free article.

4

Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.

Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA. Chetyrkin SV, et al. Among authors: voziyan pa. Kidney Int. 2005 Jan;67(1):53-60. doi: 10.1111/j.1523-1755.2005.00054.x. Kidney Int. 2005. PMID: 15610227 Free article.

5

Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.

Voziyan PA, Hudson BG. Voziyan PA, et al. Cell Mol Life Sci. 2005 Aug;62(15):1671-81. doi: 10.1007/s00018-005-5082-7. Cell Mol Life Sci. 2005. PMID: 15905958 Free PMC article. Review.

6

Pyridoxamine: the many virtues of a maillard reaction inhibitor.

Voziyan PA, Hudson BG. Voziyan PA, et al. Ann N Y Acad Sci. 2005 Jun;1043:807-16. doi: 10.1196/annals.1333.093. Ann N Y Acad Sci. 2005. PMID: 16037308 Review.

7

Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy.

Pedchenko VK, Chetyrkin SV, Chuang P, Ham AJ, Saleem MA, Mathieson PW, Hudson BG, Voziyan PA. Pedchenko VK, et al. Among authors: voziyan pa. Diabetes. 2005 Oct;54(10):2952-60. doi: 10.2337/diabetes.54.10.2952. Diabetes. 2005. PMID: 16186398

8

Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.

Scheinman JI, Voziyan PA, Belmont JM, Chetyrkin SV, Kim D, Hudson BG. Scheinman JI, et al. Among authors: voziyan pa. Urol Res. 2005 Nov;33(5):368-71. doi: 10.1007/s00240-005-0493-3. Epub 2005 Nov 15. Urol Res. 2005. PMID: 16292584

9

Glomerular injury is exacerbated in diabetic integrin alpha1-null mice.

Zent R, Yan X, Su Y, Hudson BG, Borza DB, Moeckel GW, Qi Z, Sado Y, Breyer MD, Voziyan P, Pozzi A. Zent R, et al. Kidney Int. 2006 Aug;70(3):460-70. doi: 10.1038/sj.ki.5000359. Epub 2006 Jun 14. Kidney Int. 2006. PMID: 16775606 Free article.

10

Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.

Davies SS, Brantley EJ, Voziyan PA, Amarnath V, Zagol-Ikapitte I, Boutaud O, Hudson BG, Oates JA, Roberts LJ 2nd. Davies SS, et al. Among authors: voziyan pa. Biochemistry. 2006 Dec 26;45(51):15756-67. doi: 10.1021/bi061860g. Epub 2006 Dec 6. Biochemistry. 2006. PMID: 17176098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters